{"database": "openregs", "table": "documents", "rows": [["FDA-1977-N-0023-0003", "FDA", "FDA-1977-N-0023", "Reference 3 : ISIS-2 (Second International Study of Infarct Survival) Collaborative Group, \"Randomized Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither Among 17,187 Cases of Suspected\nAcute Myocardial Infarction: ISIS-2,\" Lancet, 2:349-360, 1988. re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2003-06-17T04:00:00Z", 2003, 6, null, null, "2019-02-13T19:06:14Z", null, 0, 0, "09000064805da1ee"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1977-N-0023-0003"], "units": {}, "query_ms": 0.847937997605186, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}